Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome

Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation

COMPARISON BETWEEN THE GNRH AGONIST AND ANTAGONIST PROTOCOL IN ASSISTED REPRODUCTION DURING CONTROLLED OVARIAN STIMULATION CYCLES

The outcomes of gonadotropins releasing hormone (GnRH) antagonist cycles with and without letrozole co-treatment in patients undergoing ICSI

Duphaston-Primed VS. GnRH Antagonist Ovarian Stimulation in PCOS: A Retrospective Review of Outcomes

Impact of Premature Progesterone Rise on Intracytoplasmic Sperm Injection Outcomes Using Gonadotropin-Releasing Hormone Antagonist Protocol

Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome

Dydrogestrone-Primed Stimulation Protocol versus Conventional Antagonist Protocol in Polycystic Ovarian Syndrome Cases Undergoing ICSI

Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinica

PROGESTIN-PRIMED OVARIAN STIMULATION VERSUS GNRH ANTAGONIST IN LOW OVARIAN RESERVE PATIENTS UNDERGOING ICSI CYCLES